Alpha 2.0
Login Register
» Articles » PMID: 35328161

Comment on Li Et Al. Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study. 2021, , 2364

Overview
Journal Diagnostics (Basel)
Specialty Radiology
Date 2022 Mar 25
PMID 35328161
Authors
Laura Schramm
Affiliations
Soon will be listed here.
Abstract

In 2021, Li et al. published an article on variants and implications in pediatric neuroblastoma patients [...].

Citing Articles

Reply to Schramm, L. Comment on "Li et al. Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study. 2021, , 2364".

Li X, Sun L, Stucky A, Tu L, Cai J, Chen X Diagnostics (Basel). 2022; 12(3).

PMID: 35328170 PMC: 8947584. DOI: 10.3390/diagnostics12030617.

References
1.
Willis I . A universal nomenclature for subunits of the RNA polymerase III transcription initiation factor TFIIIB. Genes Dev. 2002; 16(11):1337-8. DOI: 10.1101/gad.998102. View
2.
Li X, Sun L, Stucky A, Tu L, Cai J, Chen X . Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study. Diagnostics (Basel). 2021; 11(12). PMC: 8700758. DOI: 10.3390/diagnostics11122364. View
3.
Schramm L, Hernandez N . Recruitment of RNA polymerase III to its target promoters. Genes Dev. 2002; 16(20):2593-620. DOI: 10.1101/gad.1018902. View
4.
Kim Y, Wang H, Sures I, Lammers R, Martell K, Ullrich A . Characterization of the PEST family protein tyrosine phosphatase BDP1. Oncogene. 1996; 13(10):2275-9. View
5.
Povey S, Lovering R, Bruford E, Wright M, Lush M, Wain H . The HUGO Gene Nomenclature Committee (HGNC). Hum Genet. 2002; 109(6):678-80. DOI: 10.1007/s00439-001-0615-0. View